World-First Lung Cancer Vaccine Trials Launched Across Seven Countries

• Lung cancer is the world's leading cause of cancer death, with about 1.8m deaths annually.
• Survival rates for advanced lung cancer are poor, but a new vaccine, BNT116, aims to change that.
• The vaccine, made by BioNTech, targets non-small cell lung cancer (NSCLC) and is in phase 1 trials.
• Trials are happening at 34 sites in seven countries, including the UK, US, and Germany.
• The vaccine uses mRNA technology to train the immune system to fight cancer cells without harming healthy cells.

Source: Slashdot